NOVEL PEPTIDE BINDER TO GLYPICAN-3 FOR TARGETED RADIOPHARMACEUTICAL THERAPY OF HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Song, Ken [1 ]
机构：
[1] RayzeBio, San Diego, CA USA
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [21] [68Ga]Ga-RYZ-GPC3: A glypican-3 targeted diagnostic radiopharmaceutical for hepatocellular carcinoma molecular imaging
    Braat, Arthur J. A. T.
    Poot, Alex J.
    Lapa, Constantin
    Lam, Marnix G. E. H.
    Weber, Wolfgang A.
    Karmann, Anna
    Yuan, Ye
    Rearden, Jessica
    Song, Ken
    Bundschuh, Ralph A.
    CANCER RESEARCH, 2024, 84 (06)
  • [22] Glypican-3 is overexpressed in human hepatocellular carcinoma
    Sung, YK
    Hwang, SY
    Park, MK
    Farooq, M
    Han, IS
    Bae, HI
    Kim, JC
    Kim, M
    CANCER SCIENCE, 2003, 94 (03): : 259 - 262
  • [23] Glypican-3: Comparison of a novel stain in immunocytochemistry and immunohistochemistry in hepatocellular carcinoma
    Kandil, D.
    Leiman, G.
    Trotman, W.
    Allegretta, M.
    Pantanowitz, L.
    Goulart, R.
    Evans, M.
    ACTA CYTOLOGICA, 2007, 51 (02) : 331 - 331
  • [24] Epigenetic regulation of glypican-3 in hepatocellular carcinoma
    Trinh, Thu L.
    Puszyk, William
    Liu, Chen
    CANCER RESEARCH, 2014, 74 (19)
  • [25] Glypican-3 as a specific biomarker for hepatocellular carcinoma
    Yao, Min
    Pan, Liu-Hong
    Yao, Deng-Fu
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (02) : 122 - 123
  • [26] Evaluation of glypican-3 in patients with hepatocellular carcinoma
    Batbaatar, Batchimeg
    Gurbadam, Unenbat
    Tuvshinsaikhan, Odonchimeg
    Narmandakh, Nyam-Erdene
    Khatanbaatar, Gerelee
    Radnaabazar, Munkhbat
    Erdene-Ochir, Dulguun
    Boldbaatar, Minjuur
    Byambaragchaa, Munkhdelger
    Amankyeldi, Yerbolat
    Chogsom, Munkhzaya
    Ganbileg, Nyamsuren
    Batdelger, Amgalantuul
    Demchig, Tserendorj
    Nyam-Osor, Lkham
    Bayartugs, Batsaikhan
    Batmunkh, Enkhtsatsral
    Munkhjargal, Batkhishig
    Lonjid, Tulgaa
    Khasbagana, Batbayar
    Batmunkh, Munkhbat
    Jav, Sarantuya
    Semchin, Munkhbayar
    MOLECULAR AND CLINICAL ONCOLOGY, 2025, 22 (01)
  • [27] Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma
    Tsuchiya, Nobuhiro
    Yoshikawa, Toshiaki
    Fujinami, Norihiro
    Saito, Keigo
    Mizuno, Shoichi
    Sawada, Yu
    Endo, Itaru
    Nakatsura, Tetsuya
    ONCOIMMUNOLOGY, 2017, 6 (10):
  • [28] Glypican-3 as a potential hepatocellular carcinoma peptide vaccine candidate for the Indonesian population
    Angelika
    Parikesit, Arli Aditya
    Jonathan, Michael
    Julianto, Nadya Marcelina
    JOURNAL OF RESEARCH IN PHARMACY, 2022, 26 (04): : 962 - 979
  • [29] Glypican-3 as a specific biomarker for hepatocellular carcinoma
    Min Yao
    Liu-Hong Pan
    Deng-Fu Yao
    Hepatobiliary&PancreaticDiseasesInternational, 2015, 14 (02) : 122 - 123
  • [30] Glypican-3 Aptamer Has Potential as a New Targeted Therapy for Hepatocellular Carcinom
    Lee, Yun Bin
    Lee, Jeong-Hoon
    Lee, Dong Hyeon
    Cho, Yuri
    Yoo, Jeong-Ju
    Cho, Young Youn
    Cho, Eun Ju
    Yu, Su Jong
    Kim, Yoon Jun
    Kim, Jong In
    Im, Jong Hun
    Lee, Jung Hwan
    Oh, Eun Ju
    Yoon, Jung-Hwan
    HEPATOLOGY, 2016, 64 : 239A - 239A
12345